Another CPT1 inhibitor, ST1326, prevented formation of B-cell lymphoma in mice (177) and CPT1 inhibitor ranolazine administered together with pyruvate dehydrogenase kinase inhibitor DCA inhibited growth of glioblastoma in mice (178). The gene discussed is CPT1A; the disease is glioblastoma.